That is very important, because the method a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and work. Simply put, we have to understand how these proteins fold if we want a drug to work. Historically, this has been a trial-and-error procedure (longtime readers). Today, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much easier to produce drugs that do what they're designed to do. This was a development nearly nobody saw. However it's going to have extensive ramifications for treating disease. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, of course, there will be a lot of financial investment chances in this area, too. Moving subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (longtime readers). That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be amazed if it drew back perhaps significantly before going greater - brownstone research stock. I have actually been covering bitcoin for a long period of time now. One of the very first research study reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I entitled my report "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time. We were mostly educating readers. However that's not the huge concern anymore. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche business. Mass, Mutual is a relied on 170-year-old organization. So think of that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a huge factor I'm bullish on it this year. future report review. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These companies raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are a lot of excellent personal companies on the verge of hitting the general public markets And I have actually been working on a new method for you to invest even before these companies go public.
This opportunity has actually been developing over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to find out all the details. Go right here to book your area totally free.
Emma Walsh here, handling editor of the Journal. Regular Diary readers understand that tech isn't our typical beat (last week). And when it pertains to tech investing, we leave it to the specialists. Luckily, we have several such specialists in our Rolodex. Our colleague Jeff Brown will be familiar to our long time readers. He is among the most accomplished tech investing experts we understand (jeff brown genome sequencing). In reality, he had a number of triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big photo and anticipate what's just around the corner.
That includes things like 5G networks, biotech, artificial intelligence, and far more. These trends are experiencing rapid growth and producing extraordinary chances for investors. I wish to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a topic I've been covering for years now. jeff brown stock predictions 2021. However despite what many readers might think, this is a trend that's just getting going. Although the COVID-19 pandemic interrupted supply chains last year, an impressive 250 million 5G-enabled devices were still sold.
And all of this ultimately led to Apple delaying the release of the 5G-enabled i, Phone 12 by two months (jeff brown investor prediction). Losing 2 months of manufacturing and sales truly impacts how many 5G devices are offered in the calendar year. When you think about all of that, offering 250 million systems is remarkable. More importantly, the delays triggered by the pandemic developed a heap of pent-up demand. And that need is now going to be pushed into 2021. In reality, I anticipate that more than 500 million 5G devices will be delivered in 2021 - jeff brown top stock pick 2021. Which's not my only 5G prediction When I've talked about 5G in the past, I have actually explained its 3 different phases.
In Phase Two, 5G devices go on sale. 5G phones and other products start to reach customers. And in Stage 3, 5G services start to be offered (jeff brown). That's when we begin to see applications operating on 5G networks. Think about things like huge multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will begin Stage Three by this summer. This begins something of a virtuous cycle: Many people do not really care about the technology. However they will care if there are amazing applications that can just be accessed with a 5G phone.
That results in more 5G apps being established. In truth, 5G is going to open up a suite of amazing applications: self-driving cars, the Internet of Things, robotic surgery, and more. All of these innovations require 5G. The investment chances moving forward will be huge. Stepping away from 5G, the next crucial innovation I visualize in 2021 is CRISPR hereditary editing. CRISPR represents "clustered regularly interspaced short palindromic repeat." It's a mouthful. However it's one of the most exciting advancements in biotechnology. At a high level, CRISPR is a technology that can edit our hereditary makeup as if it were software.
The program can crash or not function correctly. CRISPR uses a comparable idea however with our genetic code. "Typos" in our genome can lead to illness. CRISPR can remedy these "typos." For several years, CRISPR was mostly a niche technology that wasn't well understood. And throughout that time, there were actually just 3 business running in this area. However things are changing. CRISPR is no longer just theoretical. We're seeing actual results. We're treating diseases and seeing that this technology simply works. And as a result, a "2nd crop" of early-stage CRISPR business is going public and providing incredible returns. This whole industry is efficiently a greenfield chance.
There's space for lots of companies to exist in this area. the legacy report predictions. And there will be more. That's my prediction for CRISPR in 2021. I predict that two or three more hereditary modifying companies will hold their IPOs. Sticking to biotechnology, we are seeing fantastic things happening at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its newest Alpha, Fold software can precisely anticipate the folding of a protein based entirely on its amino acid series with 92. 4% accuracy. That is very important since the way a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and work.
Historically, this has been an experimental process. However now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to create drugs that do what they're developed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however several drug treatments produced using this innovation. This was one of those advancements that almost no one noticed. But it's going to have profound ramifications for treating disease. And, obviously, there will be plenty of financial investment chances in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be shocked if it pulled back possibly significantly prior to going higher. I have actually been covering bitcoin for a long period of time now. One of the first research study reports I ever released was on bitcoin - jeff brown predictions 2021. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for anybody who followed my suggestion. But at the time of that initial recommendation, I entitled my report, "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time.
However nobody is asking that question anymore. Now, we're seeing institutional money finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. jeff brown stock predictions 2021. Mass, Mutual is a 150-year-old organization. So consider that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more perk prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and claims the details depends on date as of February 2021, but we might not separately validate this claim. Offered Jeff Brown's past, he likely has a significant net worth, however we can't hammer down a precise figure at this minute. Brown is best known for his sage-like ability to pick winning innovation stocks. He invested more than 25 years investigating innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience gives him an exceptional perspective on the marketplace. He's constantly on the hunt for new chances, and he shares a lot of his finest choices in the Future Report.
That's full marks, however it's not absurdly reasoned. Brown has an excellent reputation as a stock-picker, and he effectively predicted some of the biggest economic occasions of the previous twenty years. Although he does not appear to release his choices to the public, the service's success is a direct indicator of Brown's stock-picking prowess. No one on Wall Street gets it best each time, however Jeff Brown's precise forecasts have made him legions of dedicated fans. That states a lot about his ability. The Future Report is published by Brownstone Research, a popular financial research publisher. Brownstone Research study provides numerous research services with a wide range of specializations - jeff brown latest prediction.
The company is likewise associated with Bonner & Partners, another well-respected research publisher - melania trump. On its website, Brownstone states its mission is to offer retail financiers with professional-grade research: "For too long, the very best financial investment research study has not been readily available to specific financiers. It has been normally booked for financial investment banks, hedge funds, personal equity, and high-net-worth clients. jeff brown top stock pick 2021. The mission of Brownstone Research is to make that type of proprietary research offered to any investors aiming to get an edge in the marketplaces. The goal is simple to provide unique and rewarding financial investment research study found no place else." -Brownstone Research study website excerpt from the Jeff Brown is the creator of Brownstone Research, and he likewise functions as the company's Chief Financial investment Expert.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to offer its clients. After years of stable success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a household name throughout the majority of America. If you understand even a little bit about the marketplace, you understand that he has a reputation as a King Midas of sorts. biotech stocks jeff brown. Everything he touches turns to gold! Jeff is well mindful of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge task.
In truth, Brown believes S.A.V. future report. could be "the greatest pattern of the 2020s, and he's not alone. Inspect out these quotes from other widely known S.A.V. bulls: Elon's next huge act will be weding 2 advanced innovations: synthetic intelligence and electrical automobiles. Musk hopes the combination will assist him establish the very first fully-autonomous, self-driving automobiles ever. It's absolutely nothing except the automobile market's Holy Grail. As you understand, electrical vehicles and self-driving car stocks have been huge this year, but the Wall Street device has actually been huge on hype without much tangible outcome. Despite an extreme increase in competition over the past few years, Brown still thinks Musk has the finest possibility of putting everything together.
tech might be the magic string that ties everything together. S.A.V. represents Shared Autonomous Automobile, and it could be the future of transport. Basically, this innovation would allow you to rent out your vehicle as a self-governing, self-driving taxi when you're not utilizing it. You just get out of the automobile and press a button on an app that tells the car to "join the fleet." Next thing you understand, you're relaxing on your sofa while your automobile shuttles ride-sharers around town. Most importantly, you get to keep a substantial piece of the profits. It sounds insane, but it might be closed than you believe.